Investing.com - Financial Markets Worldwide
Open in App

Hanchorbio Inc (7827)

Taiwan
Currency in TWD
151.00
-3.00(-1.95%)
Closed·

7827 Income Statement

Period Ending:
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Total Revenues
3.36--312.22
Total Revenues Growth
----
Cost Of Revenues
1.32---
Gross Profit
2.05--312.22
Gross Profit Growth
----
Gross Profit Margin %
60.87%--100%
Other Operating Expenses, Total
514.37538.05952.12679.82
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
-+4.6%+76.96%-28.6%
461.42499.21789.24548.08
52.9538.84162.88131.74
----
Operating Income
-512.32-538.05-952.12-367.6
Operating Income Growth
--5.02%-76.96%+61.39%
EBIT Margin %
-15,234.11%---117.74%
Net Interest Expenses
-1.215.141.389.98
Net Interest Expenses Growth
-+524.28%-73.18%+624.31%
Interest Expense, Total
-2.5-2.77-4.9-2.93
Interest And Investment Income
1.297.916.2812.91
Other Non Operating Expenses, Total
66.1-62.32-404.48-11.32
EBT, Excl. Unusual Items
-447.43-595.23-1,355.22-368.94
Gain (Loss) On Sale Of Assets
----
Other Unusual Items, Total
-2.92--
EBT, Incl. Unusual Items
-446.3-591.37-1,354.1-368.94
EBT, Incl. Unusual Items Growth
--32.51%-128.98%+72.75%
EBT, Incl. Unusual Items Margin
-13,270.92%---118.17%
Income Tax Expense
---22.58
Net Income to Company
-446.3-591.37-1,354.1-391.52
Minority Interest
-0.020.02-114.79
Net Income
-446.32-591.36-1,354.1-276.72
Net Income Growth
--32.5%-128.98%+79.56%
Net Income Margin %
-13,271.57%---88.63%
Preferred Dividend and Other Adjustments
----
Net Income to Common Excl. Extra Items
-446.32-591.36-1,354.1-276.72
Basic EPS - Continuing Operations
-10.09-11.36-20.36-2.26
Basic EPS - Continuing Operations Growth
--12.59%-79.3%+88.92%
Diluted EPS - Continuing Operations
-10.09-11.36-20.36-2.26
Diluted EPS - Continuing Operations Growth
--12.62%-79.25%+88.9%
Basic Weighted Average Shares Outstanding
44.2552.0766.5122.63
Diluted Weighted Average Shares Outstanding
44.2552.0766.5122.63
Dividend Per Share
----
Dividend Per Share Growth
----
EBITDA
-495.85-515.61-927.86-342.91
EBITDA Growth
--3.99%-79.96%+63.04%
EBITDA Margin %
-14,744.13%---109.83%
EBIT
-512.32-538.05-952.12-367.6
* In Millions of TWD (except for per share items)

FAQ

What was Hanchorbio’s revenue at year end?

At the end of the last reported fiscal year, Hanchorbio (7827) recorded total revenue of 312.22 million TWD.

How much revenue did Hanchorbio report in the most recent quarter?

In its most recent quarterly earnings report, Hanchorbio posted revenue of 9.54 million TWD.

What was Hanchorbio’s net income for the year?

For the full year, Hanchorbio reported net income of -276.72 million TWD.

How much net income did Hanchorbio post in the last quarter?

In the most recent quarter, Hanchorbio (7827) posted net income of -251.00 million TWD.

What was Hanchorbio’s gross profit for the year?

Gross profit for the year was reported at 312.22 million TWD.

How much gross profit did Hanchorbio generate last quarter?

Hanchorbio recorded gross profit of 0.62 million TWD in its latest quarterly report.

What was Hanchorbio’s annual operating income?

For the full year, Hanchorbio (7827) reported operating income of -367.60 million TWD.

What was Hanchorbio’s operating income last quarter?

Quarterly operating income was -273.60 million TWD.

What was Hanchorbio’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -259.81 million TWD.

What was the quarter-over-quarter change in EBITDA for Hanchorbio?

EBITDA changed by 17.19% million TWD compared to the last quarter.

What is Hanchorbio’s most recent gross profit margin?

The latest reported gross profit margin for Hanchorbio (7827) is 6.50% million TWD.

What is Hanchorbio’s most recent net income margin?

Net income margin based on recent financials is -2,630.51% million TWD.

What is Hanchorbio’s most recent EBIT margin?

Hanchorbio reported an EBIT margin of -2,867.30% million TWD based on current figures.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.